These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 21623205

  • 1. Usefulness of p16ink4a, ProEX C, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri.
    Negri G, Bellisano G, Carico E, Faa G, Kasal A, Antoniazzi S, Egarter-Vigl E, Piccin A, Dalla Palma P, Vittadello F.
    Int J Gynecol Pathol; 2011 Jul; 30(4):407-13. PubMed ID: 21623205
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Endocervical glandular lesions: a diagnostic approach combining a semi-quantitative scoring method to the expression of CEA, MIB-1 and p16.
    Pavlakis K, Messini I, Athanassiadou S, Kyrodimou E, Pandazopoulou A, Vrekoussis T, Stathopoulos EN.
    Gynecol Oncol; 2006 Dec; 103(3):971-6. PubMed ID: 16876235
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
    Cina SJ, Richardson MS, Austin RM, Kurman RJ.
    Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
    Lee S, Rose MS, Sahasrabuddhe VV, Zhao R, Duggan MA.
    Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
    [Abstract] [Full Text] [Related]

  • 14. Comparison of p16INK4a and ProEx C immunostaining on cervical ThinPrep cytology and biopsy specimens.
    Oberg TN, Kipp BR, Vrana JA, Bartholet MK, Fales CJ, Garcia R, McDonald AN, Rosas BL, Henry MR, Clayton AC.
    Diagn Cytopathol; 2010 Aug; 38(8):564-72. PubMed ID: 19937941
    [Abstract] [Full Text] [Related]

  • 15. BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix.
    Badr RE, Walts AE, Chung F, Bose S.
    Am J Surg Pathol; 2008 Jun; 32(6):899-906. PubMed ID: 18425044
    [Abstract] [Full Text] [Related]

  • 16. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT, McAlhany S, Lerwill MF, Grenert JP, Zaloudek CJ.
    Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEx C, and p16INK4a/ProEx C in cervical squamous intraepithelial lesions.
    Boucher J, Anku-Bertholet C, Temmar R, Pelmus M.
    Hum Pathol; 2009 Jun; 40(6):904-5; author reply 905-6. PubMed ID: 19442790
    [No Abstract] [Full Text] [Related]

  • 18. [Importance of the study of the expression of MIB-1 (Ki-67) for the diagnosis of endocervical glandular lesions].
    Leteurtre E, Boman F, Farine MO, Leroy JL, Gosselin B.
    Ann Pathol; 1998 Jul; 18(3):172-7. PubMed ID: 9706342
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix].
    Popovska S, Betova T, Tomov S, Gorchev G, Dikov T.
    Akush Ginekol (Sofiia); 2005 Jul; 44(5):9-13. PubMed ID: 16313047
    [Abstract] [Full Text] [Related]

  • 20. P16 as a molecular biomarker of cervical adenocarcinoma.
    Schorge JO, Lea JS, Elias KJ, Rajanbabu R, Coleman RL, Miller DS, Ashfaq R.
    Am J Obstet Gynecol; 2004 Mar; 190(3):668-73. PubMed ID: 15041997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.